bHLH/PAS proteins play important roles in tumor progression. Lost or reduced expression of single-minded homolog 2 (SIM) as well as aryl hydrocarbon receptor repressor (AHRR) has been observed in cancerous human tissues. Here, we investigated the role of aryl hydrocarbon receptor nuclear translocator (ARNT), another bHLH/PAS protein, in hepatocellular carcinoma (HCC). Using tissue microarray and immunohistochemistry, we found that intratumoral ARNT was inversely correlated with time to recurrence and overall survival of HCC patients after resection. Knockdown of ARNT in HepG2, HCCLM3 and HCCLM6 cells significantly shortened cell doubling time, increased S-phase cell populations and accelerated in vivo HCCLM6 growth and metastasis. After ARNT expression was rescued, prolonged cell doubling time and decreased S-phase cell populations were observed in HepG2, HCCLM3 and HCCLM6 cells. And, HCCLM6 growth and metastasis in vivo were remarkably inhibited. Screening by quantitative reverse-transcription PCR and PCR arrays revealed that cyclin E1, CDK2, Fos and Jun were negatively regulated by ARNT, whereas CDKN1C, CNKN2A, CDKN2B, MAPK11 and MAPK14 were positively regulated in HCC. According to the results of immunoprecipitation assay, both ARNT/ARNT and ARNT/AHRR complexes were clearly formed in HCCLM6 xenograft with increased ARNT expression. In summary, ARNT is an important regulator of HCC growth and metastasis and could be a promising prognostic candidate in HCC patients.Hepatocellular carcinoma (HCC) is the third leading cause of cancer death in the world and the second in China.1,2 The long-term prognosis of HCC patients after hepatectomy still remains a challenge, largely due to its high recurrence rate and metastasis.3 The molecular mechanisms of HCC progression need be further investigated for new insights and interventions against metastatic recurrence.Aryl hydrocarbon receptor nuclear translocator (ARNT), also known as hypoxia-induced factor-1b (HIF-1b), is one of the most important nuclear transcription factors within the basic helix-loop-helix/Per-ARNT-SIM (bHLH/PAS) superfamily. It is widely expressed in human cells, including hepatocytes. When responding to different extracellular stimuli, ARNT can form a heterodimeric complex with aryl hydrocarbon receptor (AHR), hypoxia-inducible factor-1a (HIF-1a) and its homologous factors (HIF-2a, HIF-3a), or with singleminded homolog 2 (SIM) to mediate various biological actions, such as hypoxia reaction, xenobiotic metabolism, teratogenesis, immunosuppression 4 and embryonic development.5 However, its onco-biological function is still unclear. Several prototypes of bHLH/PAS factors have been identified as being involved in tumor progression. HIF-1a promotes tumor progression and metastasis via its regulation of cancerous glycolysis, 6 proliferation, apoptosis 7 and angiogenesis.8 AHR appears to be a regulator of cell proliferation, albeit growth-inhibitory and promoting roles in MCF-7 and HepG2 cells, respectively, are observed.9 SIM is frequently lost or reduced in...